DC Funds, LP — 13F Holdings & Portfolio

CIK 1869028 · latest 13F-HR filed 2026-08-14

DC Funds, LP manages $1.3M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are TCRX (49.27%), BRNS (33.82%), HOWL (16.92%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 1, and trimmed 1.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
1600 TYSONS BOULEVARD
FIFTH FLOOR
MCLEAN, VA 22102
Phone
(703) 760-4400
Filing Manager
DC Funds, LP
MCLEAN, VA
Signatory
Dean L. Wilde II
Managing Director and CEO
Loading holdings…
AUM

$1.3M

Long-equity book

Holdings

3

Distinct positions

Period

2026-06-30

Filed 2026-08-14

Q/Q Activity

+0 / −0 / ↑1 / ↓1

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • BARINTHUS BIOTHERAPEUTICS PL$58.4K +16.0%
Show all 1

Top Trims

  • WEREWOLF THERAPEUTICS INC-$278.5K -56.8%
Show all 1

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • No exits this quarter.
Show all 0
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 TSCAN THERAPEUTICS INC TCRX 89854M101 $617.5K 49.27% 630,000 SH
2 BARINTHUS BIOTHERAPEUTICS PL BRNS 91864C107 $423.9K 33.82% 642,204 SH
3 WEREWOLF THERAPEUTICS INC HOWL 95075A107 $212.0K 16.92% 589,102 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $1.3M 3 0001398344-26-014487
2026-03-31 2026-05-14 $1.5M 3 0001398344-26-009112
2025-12-31 2026-02-13 $1.5M 3 0001398344-26-002970
2025-09-30 2025-11-10 $3.1M 3 0001398344-25-020563